Literature DB >> 24296349

Roles for MYC in the establishment and maintenance of pluripotency.

James Chappell1, Stephen Dalton.   

Abstract

MYC and MYCN have been directly implicated in the transcriptional regulation of several thousand genes in pluripotent stem cells and possibly contribute to the activity of all transcribed genes. Control of transcription by a pause-release mechanism, recruitment of positive and negative epigenetic regulators, and a general role in transcriptional amplification have all been implicated as part of the broad, overarching mechanism by which MYC controls stem cell biology. As would be anticipated from the regulation of so many genes, MYC is involved in a wide range of cellular processes including cell-cycle control, metabolism, signal transduction, self-renewal, maintenance of pluripotency, and control of cell fate decisions. MYC transcription factors also have clear roles in cell reprogramming and establishment of the pluripotent state. The mechanism by which MYC accomplishes this is now being explored and promises to uncover unexpected facets of general MYC regulation that are likely to be applicable to cancer biology. In this work we review our current understanding of how MYC contributes to the maintenance and establishment of pluripotent cells and how it contributes to early embryonic development.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24296349      PMCID: PMC3839598          DOI: 10.1101/cshperspect.a014381

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  61 in total

1.  Expression and activity of L-Myc in normal mouse development.

Authors:  K S Hatton; K Mahon; L Chin; F C Chiu; H W Lee; D Peng; S D Morgenbesser; J Horner; R A DePinho
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

2.  Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair.

Authors:  Anne Wilson; Elisa Laurenti; Gabriela Oser; Richard C van der Wath; William Blanco-Bose; Maike Jaworski; Sandra Offner; Cyrille F Dunant; Leonid Eshkind; Ernesto Bockamp; Pietro Lió; H Robson Macdonald; Andreas Trumpp
Journal:  Cell       Date:  2008-12-12       Impact factor: 41.582

3.  Transcriptional amplification in tumor cells with elevated c-Myc.

Authors:  Charles Y Lin; Jakob Lovén; Peter B Rahl; Ronald M Paranal; Christopher B Burge; James E Bradner; Tong Ihn Lee; Richard A Young
Journal:  Cell       Date:  2012-09-28       Impact factor: 41.582

4.  Hematopoietic stem cell function and survival depend on c-Myc and N-Myc activity.

Authors:  Elisa Laurenti; Barbara Varnum-Finney; Anne Wilson; Isabel Ferrero; William E Blanco-Bose; Armin Ehninger; Paul S Knoepfler; Pei-Feng Cheng; H Robson MacDonald; Robert N Eisenman; Irwin D Bernstein; Andreas Trumpp
Journal:  Cell Stem Cell       Date:  2008-12-04       Impact factor: 24.633

5.  c-Myc is essential for vasculogenesis and angiogenesis during development and tumor progression.

Authors:  Troy A Baudino; Catriona McKay; Helene Pendeville-Samain; Jonas A Nilsson; Kirsteen H Maclean; Elsie L White; Ann C Davis; James N Ihle; John L Cleveland
Journal:  Genes Dev       Date:  2002-10-01       Impact factor: 11.361

6.  A null c-myc mutation causes lethality before 10.5 days of gestation in homozygotes and reduced fertility in heterozygous female mice.

Authors:  A C Davis; M Wims; G D Spotts; S R Hann; A Bradley
Journal:  Genes Dev       Date:  1993-04       Impact factor: 11.361

7.  Generation of germline-competent induced pluripotent stem cells.

Authors:  Keisuke Okita; Tomoko Ichisaka; Shinya Yamanaka
Journal:  Nature       Date:  2007-06-06       Impact factor: 49.962

8.  Role of the murine reprogramming factors in the induction of pluripotency.

Authors:  Rupa Sridharan; Jason Tchieu; Mike J Mason; Robin Yachechko; Edward Kuoy; Steve Horvath; Qing Zhou; Kathrin Plath
Journal:  Cell       Date:  2009-01-23       Impact factor: 41.582

9.  Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts.

Authors:  Masato Nakagawa; Michiyo Koyanagi; Koji Tanabe; Kazutoshi Takahashi; Tomoko Ichisaka; Takashi Aoi; Keisuke Okita; Yuji Mochiduki; Nanako Takizawa; Shinya Yamanaka
Journal:  Nat Biotechnol       Date:  2007-11-30       Impact factor: 54.908

10.  Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds.

Authors:  Danwei Huangfu; René Maehr; Wenjun Guo; Astrid Eijkelenboom; Melinda Snitow; Alice E Chen; Douglas A Melton
Journal:  Nat Biotechnol       Date:  2008-06-22       Impact factor: 54.908

View more
  50 in total

Review 1.  Functional interactions among members of the MAX and MLX transcriptional network during oncogenesis.

Authors:  Daniel Diolaiti; Lisa McFerrin; Patrick A Carroll; Robert N Eisenman
Journal:  Biochim Biophys Acta       Date:  2014-05-22

2.  RNA degradation drives stem cell differentiation.

Authors:  Chih-Hong Lou; Eleen Y Shum; Miles F Wilkinson
Journal:  EMBO J       Date:  2015-04-21       Impact factor: 11.598

3.  miR-290/371-Mbd2-Myc circuit regulates glycolytic metabolism to promote pluripotency.

Authors:  Yang Cao; Wen-Ting Guo; Shengya Tian; Xiaoping He; Xi-Wen Wang; Xiaomeng Liu; Kai-Li Gu; Xiaoyu Ma; De Huang; Lan Hu; Yongping Cai; Huafeng Zhang; Yangming Wang; Ping Gao
Journal:  EMBO J       Date:  2015-01-20       Impact factor: 11.598

4.  Myc and the Tip60 chromatin remodeling complex control neuroblast maintenance and polarity in Drosophila.

Authors:  Katja Rust; Manu D Tiwari; Vivek Kumar Mishra; Ferdi Grawe; Andreas Wodarz
Journal:  EMBO J       Date:  2018-07-11       Impact factor: 11.598

5.  cMyc Regulates the Size of the Premigratory Neural Crest Stem Cell Pool.

Authors:  Laura Kerosuo; Marianne E Bronner
Journal:  Cell Rep       Date:  2016-12-06       Impact factor: 9.423

6.  Myc and differentiation: going against the current.

Authors:  Antonio Iavarone; Anna Lasorella
Journal:  EMBO Rep       Date:  2014-03-10       Impact factor: 8.807

7.  Myc-induced SUMOylation is a therapeutic vulnerability for B-cell lymphoma.

Authors:  Alexander Hoellein; Mohammad Fallahi; Stephanie Schoeffmann; Sabine Steidle; Franz X Schaub; Martina Rudelius; Iina Laitinen; Lisa Nilsson; Andrei Goga; Christian Peschel; Jonas A Nilsson; John L Cleveland; Ulrich Keller
Journal:  Blood       Date:  2014-08-20       Impact factor: 22.113

8.  Myc and Dnmt1 impede the pluripotent to totipotent state transition in embryonic stem cells.

Authors:  Xudong Fu; Xiaoji Wu; Mohamed Nadhir Djekidel; Yi Zhang
Journal:  Nat Cell Biol       Date:  2019-06-17       Impact factor: 28.824

9.  TGMI: an efficient algorithm for identifying pathway regulators through evaluation of triple-gene mutual interaction.

Authors:  Chathura Gunasekara; Kui Zhang; Wenping Deng; Laura Brown; Hairong Wei
Journal:  Nucleic Acids Res       Date:  2018-06-20       Impact factor: 16.971

Review 10.  Synthetic lethal screens as a means to understand and treat MYC-driven cancers.

Authors:  Silvia Cermelli; In Sock Jang; Brady Bernard; Carla Grandori
Journal:  Cold Spring Harb Perspect Med       Date:  2014-03-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.